BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 15346996)

  • 1. Greater risks of chemotherapy toxicity in elderly patients with cancer.
    Repetto L
    J Support Oncol; 2003; 1(4 Suppl 2):18-24. PubMed ID: 15346996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor prognosis in elderly patients with cancer: the role of bias and undertreatment.
    Dale DC
    J Support Oncol; 2003; 1(4 Suppl 2):11-7. PubMed ID: 15346995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy.
    Shayne M; Culakova E; Poniewierski MS; Wolff D; Dale DC; Crawford J; Lyman GH
    Cancer; 2007 Oct; 110(7):1611-20. PubMed ID: 17705197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of toxicity and toxicity profile of adjuvant chemotherapy in elderly breast cancer patients.
    Garg P; Rana F; Gupta R; Buzaianu EM; Guthrie TH
    Breast J; 2009; 15(4):404-8. PubMed ID: 19508671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
    Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic therapy for the elderly with metastatic breast cancer: a review on safety, pharmacokinetics and efficacy.
    Hamberg P; Verweij J; Seynaeve C
    Eur J Cancer; 2007 Jul; 43(10):1514-28. PubMed ID: 17482454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte colony-stimulating factors: finding the right indication.
    Lyman GH; Shayne M
    Curr Opin Oncol; 2007 Jul; 19(4):299-307. PubMed ID: 17545791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effective treatment strategy in elderly breast cancer patients].
    Boér K
    Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management.
    Crawford J; Dale DC; Lyman GH
    Cancer; 2004 Jan; 100(2):228-37. PubMed ID: 14716755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New paradigms for treating elderly patients with cancer: the comprehensive geriatric assessment and guidelines for supportive care.
    Balducci L
    J Support Oncol; 2003; 1(4 Suppl 2):30-7. PubMed ID: 15346998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer in the elderly.
    Gridelli C; Langer C; Maione P; Rossi A; Schild SE
    J Clin Oncol; 2007 May; 25(14):1898-907. PubMed ID: 17488989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.
    Gridelli C; Aapro M; Ardizzoni A; Balducci L; De Marinis F; Kelly K; Le Chevalier T; Manegold C; Perrone F; Rosell R; Shepherd F; De Petris L; Di Maio M; Langer C
    J Clin Oncol; 2005 May; 23(13):3125-37. PubMed ID: 15860872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supportive care in elderly cancer patients.
    Balducci L
    Curr Opin Oncol; 2009 Jul; 21(4):310-7. PubMed ID: 19412099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology and organ toxicity of chemotherapy in older patients.
    Balducci L; Mowry K
    Oncology (Williston Park); 1992 Feb; 6(2 Suppl):62-8. PubMed ID: 1532739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: an observational retrospective survey.
    Repetto L;
    Crit Rev Oncol Hematol; 2009 Nov; 72(2):170-9. PubMed ID: 19406660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
    Klepin HD; Hurd DD
    Bone Marrow Transplant; 2006 Nov; 38(9):585-92. PubMed ID: 16953209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical practice guidelines for the use of colony-stimulating factors in cancer treatment: Implications for oncology nurses.
    Kearney N; Friese C
    Eur J Oncol Nurs; 2008 Feb; 12(1):14-25. PubMed ID: 18291720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.